Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Screening of Serum Biomarkers for Distinguishing between Latent and Active Tuberculosis Using Proteome Microarray
Shu Hui Cao1, Yan Qing Chen2, Yong Sun3
1Department of Bacteriology and Immunology, Beijing Key Laboratory on Drug-Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute/Beijing Chest Hospital, Capital Medical University, Beijing 101149, China; Department of Laboratory Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Researchers identified potential serum biomarkers to differentiate latent tuberculosis infection (LTBI) from active tuberculosis (TB). Key antigens like Rv2031c, Rv1408, and Rv2421c showed promising diagnostic performance, aiding in TB diagnosis.
Area of Science:
- Immunology
- Infectious Diseases
- Biomarker Discovery
Background:
- Distinguishing latent tuberculosis infection (LTBI) from active tuberculosis (TB) is crucial for effective treatment and disease control.
- Current diagnostic methods may not always differentiate between LTBI and active TB accurately.
Purpose of the Study:
- To identify novel serum biomarkers for differentiating LTBI from active TB.
- To evaluate the diagnostic performance of identified candidate antigens.
Main Methods:
- Systems-level screening of 4,262 antigens using a proteome microarray on serum samples from LTBI and active TB patients.
- Analysis of antigen interaction networks and functional classification.
- Validation of candidate antigens using Enzyme-Linked Immunosorbent Assay (ELISA) and Receiver Operating Characteristic (ROC) curve analysis.
Main Results:
- 152 Mycobacterium tuberculosis (Mtb)-antigen-specific IgG levels were significantly higher in active TB patients compared to LTBI patients.
- Eleven candidate antigens were validated, with Rv2031c, Rv1408, and Rv2421c demonstrating high diagnostic potential (AUCs of 0.8520, 0.8152, and 0.7970, respectively).
- Antigen combinations and logistic regression analysis enhanced diagnostic accuracy.
Conclusions:
- Several Mtb antigens show potential as serum biomarkers for discriminating between LTBI and active TB.
- The identified biomarkers could improve the accuracy of TB diagnosis.
- Further validation is warranted for clinical application.
Related Concept Videos
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
DNA Microarrays
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

